Gene · 1889
Papers1,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular determinants underlying volume-regulated anion channel subunit-dependent oxidation sensitivity. | J Physiol | 2022 | 35861288 | PubTator, text mining | PubMed |
| Antifungal activity of dehydrocurvularin for Candida spp. through the inhibition of adhesion to human adenocarcinoma cells. | J Antibiot (Tokyo) | 2022 | 35859164 | PubTator, text mining | PubMed |
| Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension. | ACS Omega | 2022 | 35811894 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| ADAMTS18+ villus tip telocytes maintain a polarized VEGFA signaling domain and fenestrations in nutrient-absorbing intestinal blood vessels. | Nat Commun | 2022 | 35810168 | PubTator, text mining | PubMed |
| The signal axis GATA2-EDN1-AGT induced hypertension from obstructive sleep apnea-hypopnea syndrome with the clinical and animal study. | Cell Mol Biol (Noisy-le-grand) | 2022 | 35809299 | PubTator, text mining | PubMed |
| Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation. | Int J Mol Sci | 2022 | 35806438 | PubTator, text mining | PubMed |
| Association between IKBKAP polymorphisms and Hirschsprung's disease susceptibility in Chinese children. | Transl Pediatr | 2022 | 35800263 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer. | Genomics Inform | 2022 | 35794700 | PubTator, text mining | PubMed |
| Panax notoginseng Saponins Alleviate Coronary Artery Disease Through Hypermethylation of the miR-194-MAPK Pathway. | Front Pharmacol | 2022 | 35784716 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders. | Int J Mol Sci | 2022 | 35742837 | PubTator, text mining | PubMed |
| Expression of the Endothelin-1 Gene and Its Type a Receptor including Physical Activity among Patients with Acute Myocardial Infarction. | Int J Environ Res Public Health | 2022 | 35742539 | PubTator, text mining | PubMed |
| Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner. | J Bone Oncol | 2022 | 35733786 | PubTator, text mining | PubMed |
| Endothelin system expression in the kidney following cisplatin-induced acute kidney injury in male and female mice. | Can J Physiol Pharmacol | 2022 | 35704945 | PubTator, text mining | PubMed |
| Contaminated Incubators: Source of a Multispecies Enterobacter Outbreak of Neonatal Sepsis. | Microbiol Spectr | 2022 | 35703554 | PubTator, text mining | PubMed |
| Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. | BMC Cardiovasc Disord | 2022 | 35689186 | PubTator, text mining | PubMed |
| Demographic and disease characteristics associated with pain intensity, kinesiophobia, balance, and fall self-efficacy among people with osteoarthritis: a cross-sectional study. | BMC Musculoskelet Disord | 2022 | 35668383 | PubTator, text mining | PubMed |
| Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity. | Nat Chem Biol | 2022 | 35668191 | PubTator, text mining | PubMed |
| The roles of microRNAs in spinal cord ischemia-reperfusion injury. | Neural Regen Res | 2022 | 35662187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1889/papers?page=11